Definitions for "Rituximab"
A monoclonal antibody specific to CD20. Rituxamab is indicated for the treatment of patients with relapsed or refractory, low-grade or follicular, CD20-positive, B-cell non-Hodgkin's lymphoma.
(or Rituxan) is a commercial humanized antibody used for treating lymphomas.
an immunotherapy drug used to treat a variety of non-Hodgkin's lymphomas. Clinical studies are underway to determine the efficacy of Rituxan in treating chronic lymphomcytic leukemia (CLL), Waldenstrom's macroglobulinemia, and other cancers of the blood.